Advertisement

Topics

SWant Company Profile

16:07 EST 17th November 2017 | BioPortfolio

Antibodies to Calbindin D-28k, Calretinin, Parvalbumin, S-100, Calmodulin, Calsequestrin and to Na2+-Ca2+-exchangers, Ca2+ channels subunits, Ca2+ channels subunits, Ca2+ pumps, Neurotransmitters, as well as their respective antigens.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

SWant

Antibodies to Calbindin D-28k, Calretinin, Parvalbumin, S-100, Calmodulin, Calsequestrin and to Na2+-Ca2+-exchangers, Ca2+ channels subunits, Ca2+ channels subunits, Ca2+ pumps, Neurotransmitters, as ...

More Information about "SWant" on BioPortfolio

We have published hundreds of SWant news stories on BioPortfolio along with dozens of SWant Clinical Trials and PubMed Articles about SWant for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SWant Companies in our database. You can also find out about relevant SWant Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record